These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 31274341

  • 1. The Defensive Action of LYRM03 on LPS-Induced Acute Lung Injury by NF-κB/TLR4/NLRP3 Signals.
    Wang B, Wang J, Lu D, Qi N, Liu Q.
    J Invest Surg; 2021 Mar; 34(3):284-296. PubMed ID: 31274341
    [Abstract] [Full Text] [Related]

  • 2. Posttreatment With LYRM03 Protects Rats From Acute Lung Inflammation Induced by Lipopolysaccharide via Suppressing the NF-κB/MyD88/TLR4 Axis.
    Jiang Q, Wang S, Shi Y.
    J Surg Res; 2019 Nov; 243():316-324. PubMed ID: 31255931
    [Abstract] [Full Text] [Related]

  • 3. Yemazhui () ameliorates lipopolysaccharide-induced acute lung injury modulation of the toll-like receptor 4/nuclear factor kappa-B/nod-like receptor family pyrin domain-containing 3 protein signaling pathway and intestinal flora in rats.
    Li R, Yang H, Xue Y, Xianqin L.
    J Tradit Chin Med; 2024 Apr; 44(2):303-314. PubMed ID: 38504536
    [Abstract] [Full Text] [Related]

  • 4. Polygala tenuifolia willd. Extract alleviates LPS-induced acute lung injury in rats via TLR4/NF-κB pathway and NLRP3 inflammasome suppression.
    Guo S, Zhang J, Zhang Q, Xu S, Liu Y, Ma S, Hu X, Liu Y, Zhang X, Jiang R, Zhang Z, Zhang Z, Zhou Z, Wen L.
    Phytomedicine; 2024 Sep; 132():155859. PubMed ID: 38972239
    [Abstract] [Full Text] [Related]

  • 5. MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1beta secretion by a MyD88/NF-κB-dependent pathway in alveolar macrophages cell line.
    Luo M, Hu L, Li D, Wang Y, He Y, Zhu L, Ren W.
    Mol Immunol; 2017 Oct; 90():1-10. PubMed ID: 28654770
    [Abstract] [Full Text] [Related]

  • 6. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L, Li L, Lu S, Li K, Su Z, Wang Y, Fan X, Li X, Zhao G.
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation.
    Zhang C, Wang X, Wang C, He C, Ma Q, Li J, Wang W, Xu YT, Wang T.
    Front Pharmacol; 2021 Feb; 12():790072. PubMed ID: 35002723
    [Abstract] [Full Text] [Related]

  • 9. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury In Vivo and In Vitro Through the PIP2/NF-κB/NLRP3 Signaling Pathway.
    Han S, Yuan R, Cui Y, He J, Wang QQ, Zhuo Y, Yang S, Gao H.
    Front Immunol; 2022 Feb; 13():846384. PubMed ID: 35281058
    [Abstract] [Full Text] [Related]

  • 10. Fortunellin ameliorates LPS-induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF-κB/NLRP3 pathway.
    Liu D, Guo R, Shi B, Chen M, Weng S, Weng J.
    Immun Inflamm Dis; 2024 Mar; 12(3):e1164. PubMed ID: 38501503
    [Abstract] [Full Text] [Related]

  • 11. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury.
    Zhang Q, Yang C, Ma S, Guo S, Hu X, Zhou Z, Liu Y, Zhang X, Jiang R, Zhang Z, Wen L.
    J Ethnopharmacol; 2023 Sep 15; 313():116615. PubMed ID: 37164255
    [Abstract] [Full Text] [Related]

  • 12. Bakuchiol regulates TLR4/MyD88/NF-κB and Keap1/Nrf2/HO-1 pathways to protect against LPS-induced acute lung injury in vitro and in vivo.
    Zhao L, Zhang Z, Li P, Gao Y, Shi Y.
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May 15; 397(5):3301-3312. PubMed ID: 37930390
    [Abstract] [Full Text] [Related]

  • 13. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
    Zhang X, Du Q, Yang Y, Wang J, Dou S, Liu C, Duan J.
    Biomed Pharmacother; 2017 Jul 15; 91():1042-1052. PubMed ID: 28525945
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-inflammatory effect and component analysis of Chaihu Qingwen granules.
    Zhou Y, Li QX, Liao ZZ, Liu Y, Ouyang Y, Jiang WJ, Tang MT, Hu JF, Zhang W.
    J Ethnopharmacol; 2023 Dec 05; 317():116763. PubMed ID: 37315646
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Mechanism of lung and intestine combination therapy in treatment of acute lung injury by inhibiting inflammatory response based on NF-κB/NLRP3 signaling pathway and alveolar macrophage activation].
    Kou YL, Wang WB, Yan SG, Li JT, Shi J, Hui Y.
    Zhongguo Zhong Yao Za Zhi; 2022 Jan 05; 47(1):151-158. PubMed ID: 35178922
    [Abstract] [Full Text] [Related]

  • 19. Qinhuo Shanggan oral solution resolves acute lung injury by down-regulating TLR4/NF-κB signaling cascade and inhibiting NLRP3 inflammasome activation.
    Tang S, Liang Y, Wang M, Lei J, Peng Y, Tao Q, Ming T, Yang W, Zhang C, Guo J, Xu H.
    Front Immunol; 2023 Jan 05; 14():1285550. PubMed ID: 37954597
    [Abstract] [Full Text] [Related]

  • 20. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
    Niu X, Zang L, Li W, Xiao X, Yu J, Yao Q, Zhao J, Ye Z, Hu Z, Li W.
    Int Immunopharmacol; 2020 Apr 05; 81():106024. PubMed ID: 31784404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.